Showing results (121-130 of 186) with videos related to
Sort By:
Pageof 19
Clinical Therapeutics|December 16, 2021
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health BenefitNihar Desai, Jipan Xie, Yan Wang, et al.Annals of Surgery|October 7, 2011
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decisionDavid R Flum, Steve Kwon, Kara MacLeod, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 12, 2015
The clinical and cost burden of coronary calcification in a Medicare cohort: An economic model to address under-reporting and misclassificationLouis P Garrison, Jack Lewin, Christopher H Young, et al.Drug Metabolism Reviews|May 9, 2008
A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implicationsLouis P Garrison, Rick J Carlson, Josh J Carlson, et al.The American Journal of Managed Care|April 14, 2006
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic testsScott D Ramsey, David L Veenstra, Louis P Garrison, et al.Drug Safety|June 18, 2016
Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility AnalysisMarita Mann, Assegid Mengistu, Johannes Gaeseb, et al.The American Journal of Managed Care|March 23, 2012
Systematic review of comparative effectiveness data for oncology orphan drugsMindy M Cheng, Scott D Ramsey, Emily Beth Devine, et al.Plos One|February 25, 2012
Potential cost-effectiveness of universal access to modern contraceptives in UgandaJoseph B Babigumira, Andy Stergachis, David L Veenstra, et al.BMC Public Health|December 8, 2011
Estimating the costs of induced abortion in Uganda: a model-based analysisJoseph B Babigumira, Andy Stergachis, David L Veenstra, et al.Advances in Therapy|March 24, 2026
Estimating the Impact of Hemophilia A Treatment Administration on Patient Health Utility: Combining a Discrete Choice Experiment with Time Trade-Off MethodMelody S Benton, Dongzhe Hong, Mark W Skinner, et al.Pageof 19